Eli Lilly and Company Osteoporosis Drug Forteo Regrows Jaw Bone, Early Studies Show

October 18, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BOSTON, Oct 16 (Reuters) - Eli Lilly and Co's (LLY.N) osteoporisis drug Forteo can regrow bone in jaws damaged by severe bone-destroying conditions called osteonecrosis and periodontitis, doctors reported on Saturday.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase 1

Eli Lilly and Company